David S. Boyer

Active 1988–2025

93
Papers
24,261
Citations
61
h-index
90
i10-index

Citations

Citations per year for David S. Boyer1952: 1 citations1965: 2 citations1972: 2 citations1989: 3 citations1990: 2 citations1991: 5 citations1992: 2 citations1993: 6 citations1994: 4 citations1995: 1 citations1996: 4 citations1997: 3 citations1998: 5 citations1999: 1 citations2000: 4 citations2001: 1 citations2002: 3 citations2003: 2 citations2004: 4 citations2005: 9 citations2006: 21 citations2007: 70 citations2008: 81 citations2009: 69 citations2010: 98 citations2011: 99 citations2012: 155 citations2013: 207 citations2014: 215 citations2015: 215 citations2016: 237 citations2017: 203 citations2018: 189 citations2019: 765 citations2020: 764 citations2021: 835 citations2022: 580 citations2023: 539 citations2024: 852 citations2025: 414 citations2026: 11 citations1953–1964: no citations, so these years are not shown1966–1971: no citations, so these years are not shown1973–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,966 citing papers, 26.7% of this breakdownUnited Kingdom: 610 citing papers, 8.3% of this breakdownGermany: 422 citing papers, 5.7% of this breakdownChina: 416 citing papers, 5.6% of this breakdownItaly: 401 citing papers, 5.4% of this breakdownAustralia: 333 citing papers, 4.5% of this breakdownJapan: 305 citing papers, 4.1% of this breakdownSwitzerland: 300 citing papers, 4.1% of this breakdownFrance: 256 citing papers, 3.5% of this breakdownSpain: 173 citing papers, 2.4% of this breakdownCanada: 172 citing papers, 2.3% of this breakdownSingapore: 162 citing papers, 2.2% of this breakdown
0%26.7%Other 25.2%

Fields

  • Medicine83.9%
  • Biochemistry, Genetics and Molecular Biology10%
  • Immunology and Microbiology2.2%
  • Neuroscience1.5%
  • Pharmacology, Toxicology and Pharmaceutics0.7%
  • Engineering0.5%
  • Other1.2%

Topics

  • Retinal Diseases and Treatments25.8%
  • Retinal Imaging and Analysis11.3%
  • Ocular Diseases and Behçet’s Syndrome7.7%
  • Ophthalmology and Visual Impairment Studies6%
  • Glaucoma and retinal disorders5.2%
  • Retinal and Optic Conditions4.5%
  • Other39.5%

Coauthors

All papers

Open in search
  1. Ranibizumab for Neovascular Age-Related Macular Degeneration

    Authors: , , , , , , - New England Journal of Medicine 2006 cited by 5,866

  2. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander M. Eaton, Alexander Rubowitz, Alice T. Lyon, Allen Chiang, Allen C. Ho, Allen Hu, Amir Guerami, Amr Dessouki, André Corrêa Maia de Carvalho, Andrés Emanuelli, Andrew Chang, Andrew N. Antoszyk, A Francone, Anita Prasad, Armin Wolf, Arshad M. Khanani, Ashkan M. Abbey, Asma Moulana, Barbara Wihelm, Bartosz L. Sikorski, Baruch D. Kuppermann, Benjamin Wolff, Brian Jewart, K. Brian, Brian T. Chan-Kai, Calvin E. Mein, Carel B. Hoyng, Carl C. Awh, Carl Regillio, Carlos Zeolite, Caroline R. Baumal, Catherine Creuzot‐Garcher, Catherine Français Maury, Charles C. Wykoff, Charles K Newell, Chirag Jhaveri, Chris P. Lohmann, Christiana Dinah, Colin Ma, Courtney Crawford, D Wilkin Parke, Daniel Lavinsky, Daniel B. Roth, Dante J. Pieramici, Darius M. Moshfeghi, Darrin Levin, David A. Saperstein, David M. Brown, David Gaucher, David R. Lally, David Liao, David Warren Brown, Debra A. Goldstein, Dennis M. Marcus, Derek G. Chan, Dilsher S. Dhoot, Domingo Tacite, Dominik Zalewski, Edgar M. Espana, Eleonora M. Lad, Eric H. Souied, Eric Suan, Eva Eting, Federico Furno Sola, F. De Bats, Francesco Bandello, Francisco Gómez‐Ulla, François Devin, Frank G. Holz, Fred K. Chen and 163 more - The Lancet 2023 cited by 443

  3. Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karl G. Csaky, Jordi Monés, Daniel Pauleikhoff, Ramin Tadayoni, James G. Fujimoto - Ophthalmology 2019 cited by 791

  4. Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration

    Authors: , , , , , , , , , , , , , , , , , , , , - Ophthalmology 2019 cited by 512

  5. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , , , - JCI Insight 2017 cited by 518

  6. Ranibizumab for Diabetic Macular Edema

    Authors: , , , , , , , , , , , - Ophthalmology 2012 cited by 1,600

  7. Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON

    Authors: , , , , - Ophthalmology 2013 cited by 1,011

  8. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul Edwards, Carl W. Baker, Michael Novák, Ricky D. Isernhagen, Todd E. Schneiderman, Lawrence S. Halperin, Michael H. Lee, David S. Boyer, Philip J. Rosenfeld, Pamela Rath, Marc H. Levy, Robert H. Rosa, John C. Hoskins, Clement K. Chan, David M. Brown, Craig M. Greven, J Michael Jumper, Linda J. Margulies, William N. Rosenthal, Richard B. Rosen, Glenn Stoller, Fadi El Baba, W. Copley McLean, Ronald Kingsley, Alice T. Lyon, Jeffrey S. Heier, Anne E. Fung, Ingrid U. Scott, John A. Wells, Michael J. Banach, Paul M. Beer, James C. Folk, Joseph I. Maguire, Srinivas R. Sadda, Richard A. Garfinkel, Judy E. Kim, Paul Berstein, Michael Rauser, Richard A. Lewis, Barron C. Fishburne, Suber Huang, Nelson R. Sabates, Nicola Kim, Robert N. Frank, Brian C. Joondeph, Odette M. Houghton, Dean P. Hainsworth, Edward Chaum, Robert H. Millay, Raymond Iezzi, Rajendra S. Apte, Ron A. Adelman, Anita Agrawal, Neelakshi Bhagat, Lawrence Ulanski, Steven D. Schwartz, Cynthia Owsley, Alan Letson, Yu-Guang He, Cynthia A. Toth, Lawrence S. Morse, Michael J. Cooney, Sandeep Grover, Henry Ferreyra, Alexander J. Brucker, David DiLoreto, Aaron Weinberg - JAMA Ophthalmology 2022 cited by 172

  9. Faricimab Treat-and-Extend for Diabetic Macular Edema

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Suhail Alam, Arturo Alezzandrini, Virgil Alfaro, Daniel Aliseda, Arghavan Almony, Pedro Amat, Payam Amini, Andrew N. Antoszyk, Luís Arias, Riaz Asaria, Marcos Pereira de Ávila, Carl C. Awh, Joaquín Bafalluy, Carl W. Baker, Francesco Bandello, Mark Barakat, Karen Barraza, György Bátor, Caroline R. Baumal, Rubens Belfort, Chris Bergstrom, George Bertolucci, Thomas W. Bochow, Matthias Bolz, Emilia Borcz, Arnaldo Furman Bordon, David S. Boyer, Galina Bratko, Michael H. Brent, Jamin S. Brown, David M. Brown, M V Budzinskaya, S. Buffet, Stuart C Burgess, Ben Burton, Miguel Busquets, Francisco Cabrera, Carlo Cagini, Jorge I. Calzada, Peter A. Campochiaro, John S. Carlson, Alessandro Castellarin, Carlos Eduardo Cava, Voraporn Chaikitmongkol, Clement Chan, Emmanuel Chang, Jonathan S. Chang, Andrew Chang, Steve Charles, Nauman Chaudhry, Caroline Chee, Judy Chen, Fred K. Chen, Shih‐Jen Chen, Richard Cheong-Leen, Allen Chiang, Mark Chittum, David R. Chow, B. Connolly, Pierre Loïc Cornut, Karl G. Csaky, Carl J. Danzig, Arup Das, Vesselin Daskalov, Carmen Desco, Amr Dessouki, John D. Dickinson, Brian Do, Michael Dollin, Pravin U. Dugel and 297 more - Ophthalmology 2023 cited by 138

  10. Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema

    Authors: , , , , , , , , , - Ophthalmology 2014 cited by 1,115

  11. THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET

    Authors: , , , , - Retina 2016 cited by 250

  12. Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fareed Ali, Payam Amini, Andres Emanuelli Anzalotta, György Bátor, Ivan R. Batlle, Adam Berger, Ramanath Bhandari, William Bridges, Christian Brinkmann, Jamin S. Brown, Stuart C Burgess, Jorge I. Calzada, Antonio Capone, Dana Cervena, Steven Charles, Nauman Chaudhry, David R. Chow, W. Lloyd Clark, Paul Conrad, Matthew A. Cunningham, Hajir Dadgostar, Amr Dessouki, Dana Madison Deupree, Christopher A. Devine, David Eichenbaum, Jan Ernest, Nicolas Feltgen, M. J. Fenberg, Philip J. Ferrone, R. E. P. Frenkel, Scott M. Friedman, Julie Gasperini, Adam T. Gerstenblith, Ghassan Ghorayeb, Michel Giunta, Mitchell J. Goff, Liliya Golas, Joseph M. Googe, Jordana Fein, Curtis Hagedorn, Akira Hagiwara, Paul Hahn, Richard Hairston, Jason M. Handza, Vivienne Hau, Ken Hayashi, Jeffrey S. Heier, Vrinda Hershberger, Patrick Higgins, Yoshio Hirano, Shigeru Honda, Yasuko Ikegami, Yuichiro Ishida, Isao Ishikawa, Kiyoshi Ishii, Eric Jablon, Atul Jain, Yuichi Kaji, Kapil Kapoor, Ágnes Kerényi, Kazuhiro Kimura, Genichiro Kishino, Katalin Kiss, Takashi Kitaoka, James M. Klancnik, Namie Kobayashi, Jiro Kogo, Vladimír Korda, Erik Kruger, Sentaro Kusuhara and 55 more - The Lancet 2024 cited by 113

  13. Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study

    Authors: , , , , , , , , , , - EClinicalMedicine 2023 cited by 67

  14. Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials

    Authors: , , , , , , , , , , , , - Ophthalmology 2013 cited by 821

  15. Intravitreal Aflibercept for Diabetic Macular Edema

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Ophthalmology 2014 cited by 807

  16. Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy

    Authors: , , , , , , , , , , , , , , - JAMA Ophthalmology 2021 cited by 148

  17. Intravitreal Aflibercept for Diabetic Macular Edema

    Authors: , , , , , , , , , , , , , , , , , , , , - Ophthalmology 2016 cited by 421

  18. A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Irit Rosenblatt, Alexander Rubowitz, Oren Tomkins Netzer, Francesco Bandello, Antonio Ciardella, Federico Ricci, Giovanni Staurenghi, Gianni Virgili, Kristine Baumane, Guna Laganovska, Signe Ozolina, Ilze Strautmane, Bartlomiej Kaluzny, Jerzy Mackiewicz, Marta Misiuk-Hoilo, Ewa Mrukwa-Kominek, Piotr Oleksy, Krystyna Raczynska, Tomasz Zarnowski, Alfredo Adan, Javier Araiz, Anna Boixadera, Alvaro Fernández-Vega, Alfredo Garcia Layana, Francisco Gomez-Ulla, Javier Montero, Jose Maria Ruiz Moreno, David Gilmour, Timothy Jackson, Timothy Jackson, Sidath Liyanage, Luke Membrey, Geeta Menon, Niro Narendran, Sobha Sivaprasad, Daniel Alfaro, Andrew Antoszyk, Carl Baker, Ivan Batille, Brian Berger, David Boyer, William Bridges, Harold Brooks, David Brown, Margaret Chang, Daniel Chao, Sanford Chen, Courtney Crawford, Pravin Dugel, Alexander Eaton, David Eichenbaum, Jordana Fein, Leonard Feiner, Christina Flaxel, Frank Garber, Alan Gordon, Sunil Gupta, Curtis Haegedorn, George Hampton, Thomas Hanscom, Vrinda Hershberger, Peter Kaiser, Randy Katz, Arshad Khanani, Erik Kruger, Denis Marcus, Matthew Ohr, Sunil Patel, Joel Pearlman, Richard Pesavento and 21 more - Ophthalmology 2023 cited by 50

  19. LIGHTSITE III

    Authors: , , , , , , , , , , , , , , , , - Retina 2023 cited by 66

  20. Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema

    Authors: , , , , , , , , , , , , , , , - Ophthalmology 2012 cited by 508

  21. Drusen Volume as a Predictor of Disease Progression in Patients With Late Age-Related Macular Degeneration in the Fellow Eye

    Authors: , , , , , , - Investigative Ophthalmology & Visual Science 2016 cited by 168

  22. Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion

    Authors: , , , , , , , , , , , , - Ophthalmology 2014 cited by 382

  23. Anti-vascular endothelial growth factor therapy for diabetic macular edema

    Authors: , , , - Therapeutic Advances in Endocrinology and Metabolism 2013 cited by 192

  24. Higher-Order Assessment of OCT in Diabetic Macular Edema from the VISTA Study: Ellipsoid Zone Dynamics and the Retinal Fluid Index

    Authors: , , , , , , , , , , , - Ophthalmology Retina 2019 cited by 72